Apoptosis is the common cell death pathway which is initiated by a variety of different stimuli. The recognition of early apoptotic events would markedly improve reliability and convenience of apoptosis assays. In the present study the vital stain Syto R 16 in combination with the permeability marker 7-amino actinomycin D, (7-AAD) has been used to identify an early stage of apoptosis, not detected with trypan blue or 7-AAD alone or with conventional apoptosis tests and not consistently and only partly detected by the early apoptosis marker annexin V. The method was established using solid tumour cell lines treated with TNF. Subsequently we applied it to determine apoptotic populations in CD34
Summary:
Apoptosis is the common cell death pathway which is initiated by a variety of different stimuli. The recognition of early apoptotic events would markedly improve reliability and convenience of apoptosis assays. In the present study the vital stain Syto R 16 in combination with the permeability marker 7-amino actinomycin D, (7-AAD) has been used to identify an early stage of apoptosis, not detected with trypan blue or 7-AAD alone or with conventional apoptosis tests and not consistently and only partly detected by the early apoptosis marker annexin V. The method was established using solid tumour cell lines treated with TNF. Subsequently we applied it to determine apoptotic populations in CD34
+ peripheral blood progenitor cells obtained from growth factor and/or chemotherapy mobilised patients and frozen/thawed according to standard stem cell transplantation protocols. 16; 7-AAD; annexin V; apoptosis; P-glycoprotein; CD34 positive cells Apoptosis, programmed cell death initially studied in processes like embryonic and haematopoietic development, is nowadays widely studied using a variety of external stimuli such as chemotherapeutic treatment, cytokine supplementation and growth factor depletion. Apoptosis is dependent on tightly regulated cell death signalling pathways.
A variety of techniques have been developed to define a functional endpoint for apoptosis (reviewed in Refs 1-4). These include morphological examination for characteristic changes including nuclear fragmentation and formation of apoptotic bodies, 5 'the gold standard', 3 the detection of apoptosis-related DNA degradation by measuring DNA laddering, sub-G1 cells after staining with propidium iodide and DNA break formation by DNA nick end labelling by TUNEL.
In addition, plasma membrane alterations such as those related to the loss of the asymmetric distribution of phosphatidyl serine residues, resulting in exposure at the outer side of the plasma membrane, have been related to apoptosis. When using annexin V, the physiological substrate for phosphatidylserine, 6, 7 these changes have been claimed to represent an early phenomenon in the execution phase of apoptosis. 6, [8] [9] [10] [11] Recently, however, it has been claimed that the annexin V technique may not detect apoptosis in all apoptosis models. [12] [13] [14] Other plasma membrane changes, eg in antigenic determinants, have been described, suggesting that the plasma membrane may be an early target in the cascade of apoptotic events. [15] [16] [17] [18] A special group of apoptosis markers is represented by the fluorescent vital stains, compounds that passively enter the cell due to their lipophylic character and subsequently stain DNA, RNA, mitochondria or combinations (reviewed in Refs 1-4). These include Hoechst 33342, pyronin, acridine orange, rhodamin123, LDS-751, merocyanin and fluorescein diacetate, whose suitability for apoptosis detection depends on intracellular esterase activity. Mitochondria seem to play an essential role in apoptotic signal transduction. 3 Changes in the mitochondria can be detected, eg by membrane potential measurements. Other compounds such as 7-amino actinomycin D (7-AAD) and propidium iodide are able to diffuse into the cell due to increased plasma membrane permeability. [19] [20] [21] One important aspect pertinent to the choice for a particular method to detect apotosis is whether early apoptotic events should be detected. In this respect it would be important to identify the earliest apoptotic event which is irreversible and by implication leads to apoptotic cell death. The recognition of such events might strongly improve the sensitivity of apoptosis detection in patient material, when apoptotic processes may influence the outcome of treatment protocols. One such case is the application of human CD34-positive progenitor cells for stem cell transplantation after high-dose chemotherapy. 9 We have found that the quality of CD34
+ preparations strongly depends on the pre-treatment history of the transplant such as freeze-thawing. 22 Therefore, the recognition and quantification of early irreversible apoptosis not detected with conventional techniques might well contribute to clarifying the uncertainties found in literature concerning the numbers of CD34 + cells necessary for successful transplantation (Ref. 23 and references therein).
When studying a number of Syto dyes which are members of the vital DNA/RNA stains, 24 we have shown that one of these, ie Syto R 16, when used in combination with the modulator PSC-833, is a very sensitive probe in detecting plasma membrane P-glycoprotein function in tumour cell lines, as well as in CD34-positive progenitor/stem cells obtained from growth factor mobilised peripheral blood. 25 In addition, recently Frey 12 has shown that Syto dyes can be used to detect apoptosis probably by detection of changes in the structure of DNA and/or RNA. Since plasma membrane changes are among the earliest changes in the apoptotic process, in the present study the question addressed was whether Syto R 16 might be able to detect an early phase of apoptosis, characterised among others by P-glycoprotein activity changes.
The results indicate that in distinct apoptosis models, including frozen-thawed CD34 positive cells, Syto R 16 is a highly sensitive probe to detect early steps in the apoptotic process. In particular it identifies earlier irreversible events than annexin V.
Preliminary results of this work have been reported before. 
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Materials and methods
Reagents
CD34-positive cells and patients
The CD34-positive cells were present in the leucapheresis material obtained from patients with haematological or solid malignancies. The mobilisation regimen consisted of G-CSF and/or chemotherapy resulting in an increase in the numbers of CD34 positive cells in the peripheral blood. Whole leucapheresis samples were stored overnight at 4°C in autologous plasma and thereafter CD34-positive cells were purified from it using the MiniMacs system (Miltenyi Biotec) using hapten-conjugated Qbend monoclonal antibody according to the manufacturer's instructions and described in detail elsewhere. 22 Purity was checked using HPCA 2 anti-CD34 antibody and found to be Ͼ90%. Alternatively, leucapheresis samples were frozen and the CD34 purification was applied after thawing of the sample.
Cell lines
The epidermoid carcinoma cell line KB3-1 and its multidrug resistant variant KB8-5 were obtained from Dr I Roninson (Department of Genetics, University of Illinois, Chicago, IL, USA, KB3-1) or via ATCC (KB8-5). The cells were cultured in Dulbecco's minimal essential medium (DMEM; Flow Laboratories, Irvine, UK) with 7.5% FCS. KB8-5 cells were kept in the presence of the selecting concentration of colchicine for 1-2 weeks before an experiment. All cells were cultured in 5% CO 2 in a fully humidified atmosphere at 37°C and were mycoplasma-negative as detected with PCR-mediated EIA with 16S ribosomal RNA as a target.
Apoptosis induction
Adherent KB cells were incubated with TNF␣ (10 000 U/ml) for 24 h at 37°C at 5% CO 2 . After incubation cells were washed, trypsinized and washed again. Control cells were treated similarly but without addition of TNF␣.
Purified CD34 + cells or whole leucapheresis samples were frozen in N 2 using controlled freezing with a Kryo 10 (Planer Biomed, Sunbury, UK) and stored in liquid N 2 . Cells were thawed by rapid dilution (1:10) in PBS/0.1% BSA containing 100 g/ml DNAse. CD34
+ cells, frozenthawed after previous purification or purified after freeze-thawing of the leucapheresis material, were incubated for the indicated time periods at 37°C in RPMI/FCS and thereafter harvested for apoptosis detection.
Apoptosis detection
Light microscopy: Cells were centrifuged (100 l at a concentration of 0.5 × 10 6 cells/ml PBS/0.1% BSA) in a Shandon cytocentrifuge (Shandon Southern Products, Cheshire, UK) at 20 g for 10 min. After fixation in 100% methanol cells were stained with May-Grünwald-Giemsa. Cells with condensed and fragmented nuclei were scored as apoptotic and represented as a percentage of the total number of counted cells (400 per cytospin). 25 Incubation was carried out in the presence or absence of 1 m PSC833 to check the effect of P-glycoprotein activity on Syto R 16 accumulation. 25 After washing in PBS/BSA the fluorescence was recorded using flow cytometry. Syto R 16 was either combined with 7-AAD (10 l/10 6 cells) or with annexin V-Alexa 568 (see below: 'Combined staining of Syto R 16 and annexin V').
Syto
Syto R 16 and 7-AAD fluorescence combined with CD34 labelling in unpurified leucapheresis material:
Cells from unpurified leucapheresis material were first incubated with APC-labelled anti-CD34 antibody (15 min at room temperature). After washing, the cells were incubated with 7-AAD and Syto R 16 as described above. Alternatively, the CD34 labelling was performed after the 7-AAD/Syto R 16 labelling with similar results. The different subpopulations as defined by Syto R 16 and 7-AAD were defined after gating on the CD34-positive fraction using the isotype control for definition of positivity. Alternatively, CD34
+ events were acquired using a live gate (see below: 'Flow cytometry').
Annexin V with PI or 7-AAD staining: Cells were stained with FITC labelled annexin V according to the instructions of the manufacturer. In short, a washed cell pellet was resuspended in 1 ml binding buffer at a concentration of Bone Marrow Transplantation peaks in the FL1 channel, Syto R 16 was combined with Annexin V-Alexa568 which has an emission peak in the FL3 channel. Annexin V-Alexa568 staining was performed after incubation with Syto R 16 according to the manufacturer's instructions with a 1:50 dilution in binding buffer. In addition, for a comparison of staining efficacies, Annexin V-Alexa568 was used together with Annexin V-FITC.
Flow cytometry
Flow cytometry was performed using a FACSCalibur (Becton Dickinson, Immunocytometry Systems). In cases where cell lines or purified CD34
+ cells were used the fluorescence of 10 000 events was measured. In general, this resulted in a situation where viable, apoptotic and dead subpopulations could be adequately assessed (Ͼ200 events per population). For unpurified leucapheresis material the total number of white blood cells used was 10-100-fold higher depending on the CD34-positive percentage; in most cases the CD34-positive events were acquired using a live gate. An excitation wavelength of 488 nm was used in combination with standard filters to discriminate between the FL1, FL2 and FL3 channels.
Due to the spectral properties of Syto R 16 (fluorescence in FL1, with spectral overlap in FL2 and FL3, which is a main problem at concentrations exceeding 5 nm) special attention has to be paid to compensate FL3 fluorescence (7-AAD, annexin V-Alexa568) for Syto R 16 fluorescence in FL2.
Cell sorting
Cell sorting was performed using the FACS Vantage (Becton Dickinson), equipped with a Spinnaker 1161 laser, using the turbo sort option. Gating sort regions were applied on subpopulations of interest and cells were sorted with a maximal event rate of 5000/s into medium containing BSA or FCS and assayed with different apoptosis techniques immediately or after a further incubation period at 37°C. In other cases the sorted cells were plated immediately in CFU and LTC-IC assays to determine clonogenic capacity.
Clonogenic assays CFU-GM: Frozen-thawed CD34
+ cells incubated with Syto R 16 and either unsorted or sorted for Syto R 16 apoptotic subpopulations were plated in duplicate in CFU-GM medium (StemCell Technologies, Vancouver, Canada) at a concentration of 1000 or 2000 cells per well of a 24-well microtitre plate. Cells were cultured for 12 days at 37°C in a 5% CO 2 atmosphere. Aggregates of more than eight cells were counted as clusters and aggregates of more than 40 cells as colonies. In this study the numbers of clusters and colonies were taken together. For the calculation of the CFU-capacity/10 6 cells the CFU-capacity was corrected for the number of cells that were viable using the trypan blue exclusion test.
Similar experiments were performed with subpopulations of the KB3.1 cell line as defined by Syto R 16 fluorescence after apoptosis induction with TNF␣ (100-1000 cells per well).
LTC-IC:
The LTC-IC assay was performed as described by Sutherland and colleagues, using a limiting dilution assay. 28 In brief, frozen-thawed CD34 + cells incubated with Syto R 16 and either unsorted or sorted cells were plated at four different concentrations on to irradiated marrow feeders in a 96-well plate in LTBMC medium, which contained alfa-MEM, 12.5% foetal calf serum, 12.5% horse serum, 10 −4 m ␤-mercaptoethanol, 10 −6 m hydrocortisone sodium succinate, 2 mm glutamine, 0.02 mm folic acid, 0.2 mm inositol and penicillin/streptomycin (all from Gibco except hydrocortisone sodium succinate: Upjohn, The Netherlands). In parallel, 10 4 -10 5 cells/well were plated to determine the CFU output per LTC-IC (bulk assay). The cultures were incubated at 37°C in 5% CO 2 with weekly half medium changes. After 5 weeks the nonadherent and adherent cells were harvested and the CFU-GM capacity was scored in each well as described above. The LTC-IC frequencies (number of LTC-IC/CD34
+ cell) were determined with Poisson statistics. Both the frequency and the output (total number of CFUs outgrowing from LTC-ICs and expressed per CD34 + cell) were corrected for the purity and viability of the plated CD34 + cells.
Results
Syto R 16, 7-AAD and annexin V labelling in the KB3-1 cell line
During our investigations to find a convenient method for detection of early irreversible apoptosis in CD34
+ progenitor cells, we tested whether Syto R 16 was able to detect early apoptosis in tumour cell lines treated with TNF␣. We used the P-glycoprotein overexpressing KB8-5 cell line and its parental cell line KB3-1. When using the classical morphological apoptosis detection with MGG stained cytospins, TNF␣ induced apoptosis in these cell lines in a dose-dependent way (data not shown). The non-treated KB3-1 cell line showed a small population with a low Syto (Figure 1f) . From the similarity between Figure 1d and f and from independent experiments using co-labelling of annexin V-FITC and 7-AAD (not shown), it appeared that annexin V essentially labels 7-AAD positive cells (see also calculations in the legends of Figure 1 ).
In no case described in the present paper was direct necrosis observed, ie no distinct populations with increased membrane permeability (7-AAD positivity), but with intact (high) Syto R 16 fluorescence are present (in upper right quadrants of Syto R 16/7-AAD plots).
Sorting and functional characterisation of Syto R 16 labelled KB3-1 subpopulations
Since there appeared to be a marked difference between TNF␣ induced changes with Annexin V and Syto R 16, the functional characteristics of the Syto R 16 low populations was studied in more detail. Subpopulations defined by Syto R 16 fluorescence and 7-AAD staining (indicated by R1-R3 in Figure 1d ) were sorted and, to compare with standard apoptosis techniques, subsequently studied by morphology, immediately after sorting or after further incubation. The results are shown in Figure 2 and, together with Figure 1d indicate that (1) a decreased Syto R 16 fluorescence (going from R1 to R3) is paralleled by an increase of morphological apoptosis ( Figure 2a) ; (2) the trypan blue exclusion test shows only slightly increased percentages of dead cells in R2 compared to R1 (Figure 2c) .
Apart from morphology, the sorted populations were also studied for their clonogenic ability in the CFU assay: Figure 2b shows that there is a large functional difference between R1, R2 and R3, with a 14-fold decrease of clonogenic ability of cells present in R2 compared to R1 and as expected no clonogenic capacity left in R3. These results show that Syto R 16 is capable of detecting very early damage to cells before large scatter and morphological changes. (Figure 3b , which is now similar to KB3-1 cells in Figure 1c ). Upon incubation with TNF␣ there is an increase of 7-AAD positivity (compare Figure 3c and a) indicating that apoptosis has occurred. Figure 3d shows firstly that the inclusion of PSC833 in the TNF␣ treated sample, similar to the control sample, causes a shift of the majority of the population to a higher fluorescence and secondly the presence of a Syto R 16 low /7-AAD − population which in Figure 3c , in the absence of PSC833, was hidden under the main population. This shows that for apoptosis detection with Syto R 16 it is required to include a blocker of P-glycoprotein function in case cells contain functional P-glycoprotein.
Effect of the presence of P-glycoprotein on apoptosis detection by Syto
We have tested the hypothesis whether inhibition of Pglycoprotein activity could represent an early functional change during apoptosis. If so, one would expect an increase of Syto R 16 fluorescence when cells, in the absence of the inhibitor PSC833 when P-glycoprotein is fully active (a situation represented in Figure 3a ), were incubated with the apoptosis inducer TNF␣. On no occasion has such an increase been observed (illustrated in Figure 3c) .
Nonetheless, indirect evidence suggests that a large if not complete inactivation of P-glycoprotein has taken place in the populations with decreased Syto R 16 fluorescence: firstly, the apoptotic subpopulations seen in the presence of PSC833 (Figure 3d ) are located at a fluorescence intensity which coincides with the fluorescence peak in the absence of PSC833 (Figure 3c) Since R2 cells before sorting are non-permeable (7-AAD negative), the trypan positivity after sorting the R2 population indicates that the sorting procedure as such induces apoptosis, mainly in the more vulnerable (R2, but not R1 cells). It is therefore likely that the percentage apoptosis using MGG staining as measured in the sorted purified R2 population (a) overestimates the percentage present in R2 before sorting (Figure 1d ).
Apoptosis in CD34-positive stem/progenitor cells using Syto R 16 and 7-AAD labelling
When cryopreserved stem cell transplants recover after thawing, apoptosis occurs. 29 Until now the number of trypan blue excluding CD34-positive cells, either present in unpurified leucapheresis or bone marrow material or purified from fresh transplants and intended for use in transplantation, has been used as a standard of transplant quality. We have now tested the behaviour of Syto R 16 in these cells. Figures 4a and b show that, like KB 8-5 cells there is high P-glycoprotein activity in CD34 + cells; also decreases of Syto R 16 fluorescence after freeze-thawing occur which could, however, only be detected in the presence of PSC833 (Figure 4c,d ). This has been studied in more detail in Figure 5 . Like the TNF␣-treated KB cells, frozen-thawed CD34
+ cells have 7-AAD − cells with lowered Syto R 16 fluorescence. In some of the cases, two populations with lowered fluorescence are even present (Figure 5b ). Scatter properties of the R2, R3 and even part of the R4 region are very similar (Figure 5e-g ), while part of the R4 region and the whole R5 region (7-AAD + cells) have a clearly lower forward scatter (Figure 5g,h) .
As for KB8-5 cells it can be argued that the apoptotic populations have partly or completely inhibited P-glycoprotein function. This is illustrated in Figure 4 , since after P-glycoprotein inhibition with PSC833 ( Figure 4d ) the location of the apoptotic peak corresponds to the left part of the histogram seen in the absence of PSC833 (Figure 4c) . Similar results with sometimes largely different relative proportions of R2-R5, have been found thus far in over 20 different frozen/thawed CD34 + samples, obtained from different patient samples (not shown).
Sorting and functional characterisation of Syto R 16 labelled CD34
+ subpopulations Figure 6 shows an experiment on Syto R 16 defined sorted CD34
+ subpopulations similar to the one described for KB3-1 cells in Figure 2 . The R2, R3, R4 and R5 regions (for definition see Figure 5 ) have all been sorted separately. Strikingly, the R3 region in all assays is very much like R2, at least immediately after sorting. Clear differences in morphology (Figure 6a Since clonogenic capacity is an important marker for the potency of CD34 + cells to effect haematopoietic recovery, subpopulations with different Syto R 16 fluorescence were sorted and tested for clonogenic capacity in the CFU and the LTC-IC assays, detecting late and early progenitors, respectively. Table 1 shows that a decreased Syto R 16 fluorescence is paralleled by a decreased clonogenic ability. Importantly, the region R3, which, at least immediately after sorting, was very similar to R2 when using the conventional apoptosis and viability tests (Figure 6 ), had a markedly lower clonogenic capacity.
One possible pitfall of the assay may be related to heterogeneity of the cell sample. To exclude the possibility that 5-10% of CD34 − cells, which are usually present in a purified CD34
+ sample, might lead to an incorrect estimation of apoptosis in CD34 Figure 7b show that Alexa568 labelled Annexin V does 
Apoptosis in CD34
+ cells in unpurified leucapheresis material The possible clinical relevance of our observations was studied in a series of 15 unpurified frozen-thawed leucaph-eresis samples. These were treated for apoptosis detection in a similar way, but now including a post-labelling for CD34, to define apoptosis in the CD34 + fraction present in the crude sample. In 15 different samples the mean percentage of viable 7-AAD − cells was 71 (s.d. 16, range 29-95), which was close to the viability determined with trypan blue, the standard dye used to test for cellular viability. However, about half of this 7-AAD − population (corresponding to 37% of the total number of CD34-positive cells) had decreased Syto 
Discussion
Many techniques are available to detect apoptosis in a variety of cells and tissues. An important advantage of methods that detect early apoptosis would be the possibility to detect and quantify apoptosis in vivo before cells are captured by the reticulo-endothelial system, eg in leukaemia cells after chemotherapeutic treatment. A second advantage of detection of early apoptosis if proven to be predictive for later phases of apoptosis, would be the possibility for a rapid detection of/testing for treatment-induced cell death. Thirdly, in heterogeneous samples such as patient material, subpopulations of cells having different time-points of onset of apoptosis would be recognised more easily. Lastly, in the stem cell transplantation setting a more reliable estimation can be made of the number of cells potentially capable of conferring bone marrow recovery.
In this paper we demonstrate that flow cytometric detection of intracellular Syto R 16 fluorescence provides a highly sensitive and reliable detection method for early apoptosis and quality control in two apoptosis models including CD34-positive harvests for transplantation purposes. The procedure consists of a 45 min incubation with 1-5 nm of the vital stain Syto R 16 in the presence of both the permeability marker 7-amino actinomycin D (7-AAD) and the P-glycoprotein inhibitor PSC833. 7-AAD was used as an alternative for propidium iodide since compared to PI it has less spectral emission overlap in the FL2 channel, which harbours a considerable part of the Syto R 16 fluorescence; both 7-AAD and PI nevertheless detect the same population of cells, ie those which have already undergone plasma membrane permeability changes. 19 The mechanism causing the decrease in Syto R 16 fluorescence during the apoptotic process remains to be clarified. It has been reported 24 that the Syto dyes show fluorescence enhancement through binding with DNA and RNA, although for Syto R 16 this would predominantly be DNA. 30 Differences in fluorescence intensity may at least partly be related to early structural changes in DNA which may either cause decreases in fluorescence quantum yield or lead to quantitative decreases of Syto R 16 binding itself. Using several approaches we showed that the subpopulations with the lower Syto R 16 fluorescence reflect early apoptosis. These included the screening of sorted populations with conventional techniques like morphology, trypan blue and 7-AAD staining, both immediately after sorting and in time-course studies. The functional impairment of these subpopulations could clearly be demonstrated with P-glycoprotein activity measurements and clonogenic tests.
Because annexin V has been reported and generally accepted to be able to detect early apoptosis, 6, [8] [9] [10] we have compared Syto R 16 staining with annexin V staining. Our experiments with the KB3-1 cell line confirm the finding of others [12] [13] [14] that annexin V may fail to detect early apoptosis although at the same time it is able to stain those cells that have permeable membranes. Still, annexin V is potentially able to detect apoptosis earlier than conventional methods as can be demonstrated for CD34
+ cells: there is a population of Syto R 16 defined early apoptotic cells that is annexin V positive (Figure 7) . Even in this case, however, One of our goals was to detect putative P-glycoprotein activity changes occurring early during apoptosis using the Syto R 16 probe. It appeared that such an impairment of Pglycoprotein function could not be detected as a process separate from the decrease of Syto R 16 fluorescence resulting from DNA/RNA changes. The experimental evidence, however, strongly suggests that large, and most likely complete, inhibition of P-glycoprotein function has taken place in the populations with lowered Syto R 16 fluorBone Marrow Transplantation escence. It can thus still be concluded that inhibition of Pglycoprotein is an early event in apoptosis, which with the present method can not be measured independently of other early changes.
Another important conclusion drawn from our studies is that the assay described here should always include a Pglycoprotein inhibitor especially when studying freshly obtained patient material with unknown P-glycoprotein status. Moreover, whenever studying vital stains like the rhodamines, acridines or Hoechst dyes for purposes of apoptosis detection one should be aware that such dyes, as recognised more than a decade ago, 31 are substrates for drug resistance-related proteins.
The results we have reported with frozen-thawed CD34 + cells have shown a large variation in apoptotic percentages between individual patient samples, which can not be detected with conventional viability stains like trypan blue, but likely has profound effects on the correct calculation of the numbers of viable (non-apoptotic) CD34 + populations reinfused into a patient in the stem cell transplantation setting. Both the numbers of reinfused CD34
+ cells or subpopulations and the numbers of clonogenic cells correlate with bone marrow recovery. 23, 32, 33 Threshold numbers of CD34 + cells necessary for engraftment after stem cell transplantation have always been established using the numbers derived from freshly harvested leucapheresis material. Discrepancies between different studies in the optimal number of CD34 + cells/kg body weight and which range from 2-Ͼ5 × 10 6 , 23 might, apart from the underlying disease, depend on the quality of the cells after harvesting, freezing and thawing. Our results using unpurified frozen-thawed The numbers R2-R5 refer to the regions defined in Figure 5d . The frequency (number of LTC-IC/seeded CD34 + cell) as determined in the LDA assay was 1/887 (exp 1) and 1/173 (exp 2). ND = not determined.
leucapheresis material show that roughly one-third of all frozen-thawed CD34 + cells represent early apoptotic cells which can not be detected with standard viability/apoptosis assays. The present results indicate that the inclusion of an assay for detection of early apoptosis should guide stem cell collection procedures and in addition help to define more accurate threshold values for these cells for successful haematopoietic recovery.
It remains to be investigated whether the presently described method would be suitable. The most updated protocol for CD34 enumeration is offered by ISHAGE using concomitant CD34, CD45 and 7-AAD labelling. 34 Substitution of 7-AAD for Syto In addition, the expression of markers reported to be important for stem cell homing such as L-selectin, 35 integrins 36 or CXCR4 37 should be determined on these newly defined non-apoptotic cells. In this respect it is noteworthy that we have reported that the freeze-thawing process causes a large loss of L-selectin expression on CD34 + cells, 22 a result that might be biased by the presence of early apoptotic cells.
In conclusion, the present study establishes an early apoptosis marker that correlates with decreases of clonogenicity in cell lines and in normal CD34-positive progenitor cells. Inclusion of the present protocol in the monitoring procedures for stem cell quality should guide mobilisation and increase the insight in the doses of CD34-positive cells or subpopulations necessary for successful engraftment. 
